Breaking News
0

Sunesis Pharmaceuticals Inc (SNSS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Sunesis Pharma's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.5400 +0.0114    +2.16%
19/02 - Closed. Currency in USD ( Disclaimer )
After Hours
0.5445
+0.0045
+0.8333%
17:07:03 - Real-time Data
Type: Equity
Market: United States
ISIN: US8673287004 
CUSIP: 867328700
  • Volume: 294,799
  • Bid/Ask: 0.5300 / 0.5916
  • Day's Range: 0.5200 - 0.5500
Sunesis Pharma 0.5400 +0.0114 +2.16%

SNSS Overview

 
Information about the Sunesis Pharmaceuticals Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close0.5286
Day's Range0.52 - 0.55
Revenue240K
Open0.55
52 wk Range0.2 - 7.69
EPS - 0.8
Volume294,799
Market Cap32.63M
Dividend (Yield)N/A (N/A)
Average Vol. (3m)675,992
P/E RatioN/A
Beta2.45
1-Year Change - 90.95%
Shares Outstanding60,421,509
Next Earnings DateMar 07, 2019
What is your sentiment on Sunesis Pharma?
or
Market is currently closed. Voting is open during market hours.

Sunesis Pharmaceuticals Inc News


Sunesis Pharmaceuticals Inc Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Buy Buy Buy Buy Strong Sell
Technical Indicators Strong Buy Strong Buy Strong Buy Strong Buy Strong Sell
Summary Strong Buy Strong Buy Strong Buy Strong Buy Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Harami Bullish 30 Current
Harami Cross 30 Current
Hanging Man 30 Current
Dragonfly Bearish 30 Current
Doji Star Bearish 1H Current
Hanging Man 1H Current
Dragonfly Bearish 1H Current
Harami Bearish 1H Current
Harami Cross Bearish 1H Current
Belt Hold Bearish 1D Current
Completed Patterns
Engulfing Bearish 30 1 Feb 19, 2019 03:00PM
Evening Doji Star 30 1 Feb 19, 2019 03:00PM
Evening Star 30 1 Feb 19, 2019 03:00PM

Sunesis Pharmaceuticals Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 0.5400 0.5300 0.5916 294,799 +2.16% USD 19/02  
  Stuttgart 0.464 0.464 0.487 0 +1.53% EUR 03:09:00  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 170.93 171.44 169.49 +0.51 +0.30% 18.97M 19/02  
  Alphabet A 1,126.51 1,129.64 1,116.64 +6.88 +0.61% 1.10M 19/02  
  Facebook 162.29 164.15 160.33 -0.21 -0.13% 14.35M 19/02  
  Tesla 305.64 311.54 305.47 -2.24 -0.73% 4.17M 19/02  
  Netflix 361.92 365.00 355.32 +5.05 +1.42% 7.40M 19/02  
  Arts-Way 2.660 3.810 2.400 +0.730 +37.82% 8.69M 19/02  
  Amazon.com 1,627.58 1,634.00 1,600.56 +19.63 +1.22% 3.68M 19/02  
  US Global 1.290 1.400 1.120 +0.170 +15.18% 368.55K 19/02  
  Vale ADR 12.190 12.320 12.135 -0.140 -1.14% 27.91M 19/02  
  Alibaba 170.18 171.15 166.50 +4.03 +2.43% 12.98M 19/02  

Sunesis Pharmaceuticals Inc Company Profile

IndustryMajor Drugs
SectorHealthcare
Employees

34

Equity Type

ORD

Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The Company offers QINPREZO (vosaroxin), which is a product candidate for the treatment of acute myeloid leukemia (AML). Vosaroxin is an anticancer quinolone derivative (AQD). The Company's other kinase inhibitor pipeline include TAK-580, SNS-062 and SNS-229. TAK-580 is an oral, investigative drug selective for pan-Raf kinase inhibition, in patients with relapsed or refractory solid tumors. SNS-062 is a non-covalently binding inhibitor of Bruton's tyrosine kinase (BTK). The Company has completed the pre-clinical studies for SNS-062. SNS-229 and SNS-510 are two PDK1 inhibitors. PDK1 is a kinase and mediator of Phosphoinositide 3-kinase/AKT (PI3K/AKT) signaling, which is a pathway involved in cell growth, differentiation, survival and migration.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States) Start Trading
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SNSS Comments

Write your thoughts about Sunesis Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Feb 05, 2018 5:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i suggest SNSS has seen it's highs for now.
Reply
0 0
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email